Aclaris Therapeutics ACRS Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aclaris Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aclaris Therapeutics's short-term investments?
- Aclaris Therapeutics (ACRS) reported short-term investments of $76.76M in Q1 2026.
- How has Aclaris Therapeutics's short-term investments changed year-over-year?
- Aclaris Therapeutics's short-term investments increased by 2.4% year-over-year, from $74.96M to $76.76M.
- What is the long-term trend for Aclaris Therapeutics's short-term investments?
- Over 5 years (2020 to 2025), Aclaris Therapeutics's short-term investments has grown at a 17.2% compound annual growth rate (CAGR), from $32.07M to $70.79M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.